Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events
S Mora, N Rifai, JE Buring, PM Ridker - Circulation, 2008 - Am Heart Assoc
Background—Although guidelines recommend measuring fasting lipids for initial screening
of adults without cardiovascular disease (CVD), recent studies suggest that nonfasting …
of adults without cardiovascular disease (CVD), recent studies suggest that nonfasting …
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
E Ingelsson, EJ Schaefer, JH Contois, JR McNamara… - Jama, 2007 - jamanetwork.com
ContextEvidence is conflicting regarding the performance of apolipoproteins vs traditional
lipids for predicting coronary heart disease (CHD) risk. ObjectivesTo compare performance …
lipids for predicting coronary heart disease (CHD) risk. ObjectivesTo compare performance …
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D: A: D) …
Background With the aging of the population living with HIV, the absolute risk of
cardiovascular disease (CVD) is increasing. There is a need to further facilitate the …
cardiovascular disease (CVD) is increasing. There is a need to further facilitate the …
Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets …
J Shepherd, P Barter, R Carmena, P Deedwania… - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—The Treating to New Targets study showed that intensive lipid-lowering
therapy with atorvastatin 80 mg/day provides significant clinical benefit beyond that afforded …
therapy with atorvastatin 80 mg/day provides significant clinical benefit beyond that afforded …
Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic …
Sharp Collaborative Group - American heart journal, 2010 - Elsevier
BACKGROUND: Lowering low-density lipoprotein (LDL) cholesterol with statin therapy has
been shown to reduce the incidence of atherosclerotic events in many types of patient, but it …
been shown to reduce the incidence of atherosclerotic events in many types of patient, but it …
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial …
P Giannuzzi, PL Temporelli, R Marchioli… - Archives of internal …, 2008 - jamanetwork.com
Background Secondary prevention is not adequately implemented after myocardial
infarction (MI). We assessed the effect on quality of care and prognosis of a long-term …
infarction (MI). We assessed the effect on quality of care and prognosis of a long-term …
C‐reactive protein and coronary heart disease: a critical review
JP Casas, T Shah, AD Hingorani… - Journal of internal …, 2008 - Wiley Online Library
Modestly elevated baseline concentrations of C‐reactive protein (CRP), the classical acute
phase protein, are associated with the long‐term risk of coronary heart disease in general …
phase protein, are associated with the long‐term risk of coronary heart disease in general …
Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids
J Cao, KA Schwichtenberg, NQ Hanson… - Clinical …, 2006 - academic.oup.com
Background: The sum of eicosapentaenoic acid (EPA, 20: 5 ω3) and docosahexaenoic acid
(DHA, 22: 6 ω3) in erythrocyte membranes, termed the omega-3 index, can indicate …
(DHA, 22: 6 ω3) in erythrocyte membranes, termed the omega-3 index, can indicate …
From vulnerable plaque to vulnerable patient—part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report
Screening for early-stage asymptomatic cancers (eg, cancers of breast and colon) to prevent
late-stage malignancies has been widely accepted. However, although atherosclerotic …
late-stage malignancies has been widely accepted. However, although atherosclerotic …
Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review
Objective: To determine the accuracy of assessing cardiovascular disease (CVD) risk in the
primary prevention of CVD and its impact on clinical outcomes. Design: Systematic review …
primary prevention of CVD and its impact on clinical outcomes. Design: Systematic review …